NCT07020793View on ClinicalTrials.gov

Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy.

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

March 30, 2025

Conditions

the Presence of Subretinal Fluid (SRF)

Interventions

PROCEDURE

green subthreshold laser therapy

The intervention consists of green subthreshold laser therapy delivered using the Norlase µSec™ Technology, a novel microsecond-pulsed laser platform specifically designed for retinal treatments.

Trial Locations (1)

80131

university of Naples Federico II, Naples

All Listed Sponsors

lead

Federico II University

OTHER

NCT07020793 - Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy. | Biotech Hunter | Biotech Hunter